First Horizon Advisors, Inc. Bio Rad Laboratories, Inc. Transaction History

First Horizon Advisors, Inc.

$3.81 Billion
Q2 2025

A detailed history of First Horizon Advisors, Inc. transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, First Horizon Advisors, Inc. holds 241 shares of BIO stock, worth $63,674. This represents 0.0% of its overall portfolio holdings.

Number of Shares

241

Previous 233 3.43%

Holding current value

$63,674

Previous $56,000 3.57%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 05, 2025	BUY	$216.56 - $256.68 $1,732 - $2,053	8 Added 3.43%	241 $58,000
Q1 2025 Apr 28, 2025	SELL	$243.0 - $367.0 $729 - $1,101	-3 Reduced 1.27%	233 $56,000
Q4 2024 Feb 03, 2025	SELL	$313.15 - $374.28 $4,384 - $5,239	-14 Reduced 5.6%	236 $77,000
Q3 2024 Nov 08, 2024	SELL	$263.97 - $344.64 $5,543 - $7,237	-21 Reduced 7.75%	250 $83,000
Q2 2024 Jul 19, 2024	SELL	$268.26 - $339.48 $34,605 - $43,792	-129 Reduced 32.25%	271 $74,000
Q1 2024 Apr 26, 2024	BUY	$304.11 - $351.99 $1,520 - $1,759	5 Added 1.27%	400 $138,000
Q4 2023 Feb 06, 2024	BUY	$269.37 - $365.04 $7,003 - $9,491	26 Added 7.05%	395 $127,000
Q3 2023 Oct 27, 2023	BUY	$350.25 - $422.63 $3,852 - $4,648	11 Added 3.07%	369 $132,000
Q2 2023 Aug 03, 2023	SELL	$359.49 - $486.4 $10,065 - $13,619	-28 Reduced 7.25%	358 $135,000
Q1 2023 May 15, 2023	BUY	$418.69 - $503.0 $1,256 - $1,509	3 Added 0.78%	386 $184,000
Q4 2022 Feb 10, 2023	BUY	$351.71 - $456.01 $9,847 - $12,768	28 Added 7.89%	383 $161,000
Q3 2022 Nov 09, 2022	SELL	$412.59 - $563.26 $68,902 - $94,064	-167 Reduced 31.99%	355 $147,000
Q2 2022 Aug 02, 2022	BUY	$463.67 - $597.16 $146,983 - $189,299	317 Added 154.63%	522 $258,000
Q1 2022 May 10, 2022	SELL	$524.57 - $735.42 $19,933 - $27,945	-38 Reduced 15.64%	205 $115,000
Q4 2021 Feb 09, 2022	BUY	$708.84 - $794.68 $16,303 - $18,277	23 Added 10.45%	243 $183,000
Q3 2021 Nov 15, 2021	SELL	$657.71 - $825.77 $26,308 - $33,030	-40 Reduced 15.38%	220 $164,000
Q3 2021 Nov 09, 2021	BUY	$657.71 - $825.77 $36,174 - $45,417	55 Added 26.83%	260 $193,000
Q1 2021 May 11, 2021	BUY	$547.01 - $662.35 $2,735 - $3,311	5 Added 2.5%	205 $117,000
Q2 2020 Jul 31, 2020	SELL	$334.87 - $493.06 $8,371 - $12,326	-25 Reduced 11.11%	200 $90,000
Q2 2019 Aug 05, 2019	SELL	$286.93 - $312.59 $3,730 - $4,063	-13 Reduced 5.46%	225 $0
Q1 2019 Apr 26, 2019	BUY	$224.3 - $317.41 $2,915 - $4,126	13 Added 5.78%	238 $0
Q3 2018 Nov 05, 2018	BUY	$289.28 - $326.15 $65,087 - $73,383	225 New	225 $0
Q3 2018 Nov 05, 2018	SELL	$289.28 - $326.15 $65,087 - $73,383	-225 Closed	0 $0
Q2 2017 Aug 14, 2017	BUY	N/A	225	225 $0

Others Institutions Holding BIO

# of Institutions

438

Shares Held

19.5M

Call Options Held

12.7K

Put Options Held

14.4K

View Full List

About BIO-RAD LABORATORIES, INC.

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $6.51B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

More about BIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Horizon Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Horizon Advisors, Inc. with notifications on news.

Account

First Horizon Advisors, Inc. Bio Rad Laboratories, Inc. Transaction History